Shandong, China

Qingping Chen

This inventor holds 1 USPTO granted patent. Top assignees: Bloomage Biotech (Tianjin) Co., Ltd., Bloomage Biotechnology Corporation Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qingping Chen. Retrieved from https://idiyas.com/inventor/qingping-chen-wnhpw1gq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Qingping Chen and His Patent on Ergothioneine Stabilization.

Introduction. Qingping Chen is an inventor associated with Shandong, China. His patent work concerns stabilizing ergothioneine, a compound used in compositions developed for biotechnology and related applications.

Latest Patents. Chen is associated with 1 patent: “Use of Hyaluronic Acid or Salt Thereof and/or Trehalose in Stabilizing Ergothioneine, and Ergothioneine Composition Containing Hyaluronic Acid or Salt Thereof and/or Trehalose.” The invention describes using hyaluronic acid or its salts, trehalose, or both to stabilize ergothioneine in a composition.

Career Highlights. Chen is associated with Bloomage Biotechnology Corporation Limited and Bloomage Biotech (Tianjin) Co., Ltd. His listed patent reflects work on formulation stability and the use of stabilizing ingredients in ergothioneine compositions.

Collaborations. Chen’s listed coworkers include Yujie Wei and Zhen Lu. Their names are associated with his patent-related work.

Conclusion. Qingping Chen’s recorded invention focuses on stabilizing ergothioneine with hyaluronic acid or its salts and/or trehalose, connecting his patent activity with biotechnology companies and collaborators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…